Routine Preoperative Testing and Risk Assessment: An Ethical Imperative
Routine preoperative testing is NOT ethical when applied indiscriminately, but targeted risk assessment and stratification based on patient-specific factors IS ethically required and represents the standard of care.
The Ethical Foundation
The Canadian Cardiovascular Society explicitly states: "There is an ethical requirement to accurately apprise patients about the benefits and risks of surgery" 1. This ethical obligation forms the cornerstone of preoperative evaluation—providing patients with accurate risk information is essential for informed consent and shared decision-making, which are fundamental ethical principles in medical practice.
However, the ethics become problematic when testing is "routine" rather than indicated:
Mandatory testing without informed consent violates patient autonomy 2. When practices require blanket preoperative laboratory testing, they often rely on "presumed consent" rather than true informed consent, which is ethically flawed 2.
Routine testing causes harm without benefit: Studies consistently show that indiscriminate preoperative testing identifies abnormalities in 2.5-60% of cases but changes clinical management in only 0-51% of those abnormal findings 3. This creates false positives, unnecessary follow-up testing, patient anxiety, surgical delays, and increased costs—all representing harm 4.
The Evidence-Based Ethical Framework
What IS Ethically Required:
Risk stratification should be performed for:
- Patients ≥45 years old undergoing noncardiac surgery requiring overnight hospitalization 1
- Patients 18-44 years with known significant cardiovascular disease 1
- Any patient where clinical history or examination suggests unstable cardiac conditions 1
The ethical approach prioritizes:
Clinical assessment first: A thorough history and physical examination should guide all testing decisions 5, 6, 7. The 2014 ACC/AHA guidelines emphasize that testing should only be performed "if it will change management" 5, 6.
Selective, indicated testing only:
- NT-proBNP/BNP measurement is recommended (strong recommendation) for patients ≥65 years or 45-64 years with cardiovascular disease 1
- ECG is reasonable for patients with known coronary disease or structural heart disease undergoing intermediate-to-high risk surgery 5, 6
- Routine ECG is NOT recommended for asymptomatic patients undergoing low-risk surgery (Class III: No Benefit) 5, 6
Echocardiography: Routine preoperative echocardiography is NOT recommended for risk assessment (Strong Recommendation) 1. It should only be obtained when clinical examination suggests undiagnosed severe valvular disease, cardiomyopathy, or pulmonary hypertension 1.
What Is NOT Ethically Justified:
The following represent unethical practices:
- Routine preoperative testing in low-risk patients: Multiple guidelines explicitly state routine testing provides "no benefit" 5, 6, 7
- Mandatory testing as a condition for surgery access: This violates patient autonomy and informed consent principles 2
- "Preop status" or "surgical screening" orders without specific clinical indication 3
- Routine coronary angiography (Class III: No Benefit) 5, 6
- Routine stress testing for low-risk surgery (Class III: No Benefit) 5, 6
The Ethical Algorithm
For elective surgery, the ethical approach follows this sequence:
Assess surgical urgency:
Stratify patient risk:
Order only indicated tests:
Communicate risk explicitly: Use absolute risk estimates (e.g., "7 out of 100 patients with your risk factors experience complications") rather than relative risk 1
Common Pitfalls to Avoid
Defensive medicine concerns: In India and other jurisdictions, clinicians face medicolegal pressure to over-test 8. However, adhering to guideline-driven protocols that document rationale for selective testing actually provides better medicolegal protection than indiscriminate testing 8.
The "routine" trap: Hospital protocols that mandate testing create ethical problems. The 2002 ASA Practice Advisory notes that "global designations such as 'preop status' or 'surgical screening' are not considered specific clinical indications" 3.
Resource allocation: The 2025 ESAIC guidelines acknowledge that "mounting affordability challenges" and staff shortages require judicious use of resources 9. Unnecessary testing diverts resources from patients who truly need evaluation.
The Bottom Line
Risk assessment and stratification are ethically required—but only when targeted, evidence-based, and performed with informed consent. The ethical violation occurs when testing becomes "routine" rather than indicated, when it's mandatory rather than consensual, and when it's applied without consideration of whether results will actually change management or improve outcomes. The evidence overwhelmingly supports selective, risk-stratified testing over blanket protocols 7, 10, 4.